key: cord-0965290-hvo5smwx
authors: Al-zoubi, Nabil A.; Obeidat, Basil R.; Al-Ghazo, Mohammad A.; Hayajneh, Wail A.; Alomari, Abdelkarim H.; Mazahreh, Tagleb S.; Al-Faouri, Ibrahim G.; Obeidat, Khaled; Issa, Ali Banni; Aleshawi, Abdelwahab
title: Prevalence of positive COVID-19 among asymptomatic health care workers who care patients infected with the novel coronavirus: A retrospective study
date: 2020-07-11
journal: Ann Med Surg (Lond)
DOI: 10.1016/j.amsu.2020.06.038
sha: 566583c1683c66519e8ba0aa3e492e79bdc946f5
doc_id: 965290
cord_uid: hvo5smwx

BACKGROUND: Limited information is available about COVID-19 infections among health care workers. Sensitive detection of COVID-19 cases in health care workers is crucial for hospital infection prevention policy, particularly for those who work with vulnerable patients. The aim of this study is to describe the prevalence of positive COVID-19 among asymptomatic health care workers who took care of patients with COVID-19 during the pandemic. METHODS: This retrospective study included all health care workers at King Abdullah University Hospital who take care of patients infected with COVID-19 patients from March 18, 2020 to April 29, 2020. They were tested for COVID-19 infection by use of real-time reverse-transcriptase rRT-PCR on samples from nasopharyngeal swabs. RESULTS: A total number of 370 health care workers were screened. The majority were nurses followed by physicians and other personnel. This study showed that all asymptomatic health care workers were tested negative for COVID-19Q. CONCLUSION: Unexpectedly, the prevalence of positive COVID-19 among asymptomatic health care workers who take care of patients infected with the novel coronavirus was 0%. This result must be cautiously interpreted. Further studies are needed in order to find effective strategy of screening health care workers to insure a safe working environment.

COVID-19 is a serious illness that currently has no known treatment or vaccine and is spreading in an immune naive population. Deaths are rising steeply, and health systems are under strain. 1 Since the first reported case of COVID-19 in Wuhan, China, at the end of 2019, COVID-19 has rapidly spread throughout China and has also involved many other countries despite global effort s to prevent its spread. 2 On March 2, 2020, the first case of COVID-19 was diagnosed in Jordan to a patient who came from Italy. Total number of cases reached 448 by May 1, 2020. 113 of them were admitted to King Abdullah University Hospital (KAUH) which is the only hospital that deals with COVID-19 patients in the north of Jordan.

Health care workers are essential workers defined as paid and unpaid persons serving in health care settings who have the potential for direct or indirect exposure to patients or infectious materials. 3 It is critical to ensure the health and safety of HCWs, both at work and in the community. 3 They are at increased risk of contracting communicable diseases, including dropletspread respiratory viruses, because of their high level of exposure at work. 4 The idea of implementing a screening regimen to determine the prevalence of COVID-19 among our HCWs using real-time reverse--transcriptase RT-PCR on nasopharyngeal samples was to assess the subclinical transmission of the disease among HCWs, evaluate our protective measures and to help in making decisions regarding staffing and protection of HCWs in the hospital during the COVID-19 pandemic. To the best of our knowledge, very few studies have been conducted about the prevalence of COVID-19 among asymptomatic HCWs during coronavirus pandemic.

This study was approved by IRB of Jordan University of Science and Technology. It was a retrospective single center study. Inclusion criterion were all asymptomatic HCWs including physicians, nurses and other personnel (housekeepers, porters and administrative staff) who were assigned to deal with COVID-19 patients at KAUH between March 18, 2020 to April 29, 2020.

The doctor/patient ratio was 1/20 while nurse/patient ratio was 1/5-10. A total number of 370

HCWs were voluntarily screened for COVID-19 by nasopharyngeal swabs between 22 to 29 April 2020. Sample collection was taken by our trained team and the swabs were tested for COVID-19 RNA using real-time reverse--transcriptase rRT-PCR. Data on age, sex and occupational categories were also analyzed.

HCWs who had any symptoms suggestive of COVID-19 have been excluded from this study.

HCW with comorbidities (diabetes, hypertension, respiratory diseases and other chronic medial illness) and pregnant ladies were not included because they were already excluded from work during this period. This study was conducted according to STROCSS 2019 guideline. 5

Total numbers of HCWs were 3000 which were reduced to about 50% (1500) during this pandemic. A total number of 385 HCWs were involved in direct contact with COVID-patients.

Only of 370 HCWs were screened while 15 were unable to do the test. The asymptomatic HCWs screened for Covid-19 include the following occupational categories: 61.62% nurses (228 of 370), 31.35% physicians (116 of 370) and 7.02% other personnel including; housekeepers, porters and administrative staff (26 of 370). The average age was 32.02 years with the majority of HCWs was males 67% (248 of 370). This study showed that all asymptomatic HCWs were tested negative (Table 1) . Therefore, unexpectedly, the prevalence of positive-COVID-19 among asymptomatic HCWs who take care of patients infected with the novel coronavirus was 0%.

Since December 2019, the world has been in the grip of the severe acute respiratory syndromecoronavirus 2 and the disease it causes, coronavirus disease 2019 (COVID-19). 6 Since then, the spread of COVID-19 has increased exponentially, with the World Health Organization (WHO) declaring a pandemic on 11 March. 7 They are at high risk of morbidity and mortality due to health care-associated infections. 8 It has been estimated that 10% or more of all those infected with COVID-19 in some European countries are HCWs. 4 In Italy, HCWs experienced high rates of infection and death. 9 Little is known about the effectiveness of personal protective equipment (PPE) for HCWs who take care of patients infected with COVID-19. 10 On the other hand, other studies showed that the prevalence of COVID-19 amongst HCWs will depend upon a range of factors, including the availability of PPE, the healthcare setting and access to testing.

How well the country handles the Covid-19 crisis depends largely on how effectively health workforce is used. 11 But, it is also necessary to protect the health and safety of this essential national workforce. 4 Therefore, our local infection control committee started before the beginning of this pandemic in Jordan to educate HCWs about caring for COVID-19 patients regarding hand hygiene, donning and doffing PPE. Types of PPE used in KAUH were: gloves, N95 masks with tight seal around mouth and nose, face and eye protection including face shields and goggles, clothing which includes gowns, aprons, head covering, and shoe covers. Moreover, we started to establish policies and modify regulations to protect HCWs during these challenging times. As a result, our hospital started to operate at less than half capacity in order to decrease workload and to prioritize resources. In order to minimize the risk to the HCWs, only necessary procedures were allowed. Aerosol generation procedures were limited to negative pressure rooms, they were undertaken by most expert doctors or nurses available and only necessary HCWs were present in the room. HCWs with comorbidities (DM, HTN, respiratory diseases and other chronic medial illness) and pregnant ladies were exempted from work during this period.

We also adopted a policy which allows every HCW to take two weeks of home self-isolation after finishing working shift (We divided the 385 HCWs into 14 groups each group contains about 27 personnel who work 24 hours. This would provide about 2 weeks of home isolation for each HCW). Moreover, we separated wards that could be contaminated with the virus from other low risk facilities and we minimized the time of contact between HCWs and infected patients by limiting unnecessary procedures, decreasing the communication times between infected patients and HCWs provided that the patient care is not affected and by trying as much as possible to do many tasks in the same round as taking vital signs, giving medications, distributing meals and doing beddings.

Early in the pandemic crisis in Jordan (first 5 weeks) there were shortage of PCR-kit due to supply chain problems, the priority was to test only suspected patients and symptomatic HCWs.

Taking into account that not all cases are symptomatic and some people may be infectious before they develop symptoms, many HCWs were worried about their risk of exposing family members to the virus. 4 As a result, there was a need for HCWs screening protocol that provides data base about the prevalence of COVID-19 infection among our staff. Therefore, a screening regimen has been proposed for all HCWs who work in direct contact with COVID-19 patients including physicians, nurses and other personnel.

Given the high prevalence of mild clinical presentations that may go undetected 5 and after the availability of PCR-kit, we decided to changed our strategy to be sure that our HCWs are free of infection by both the PCR test and home-isolation period. So, we started to screen all asymptomatic HCWs with any history of contact with COVID-19 patients.

We think that the advantage of having an objective regimen by lab test will help in decreasing the stress and worries of the HCWs about their risk of having the virus 4 , to reduce the risk of transmitting COVID-19 from HCWs to their colleagues or to other non-COVID-19 patients and to be able to formulate policies regarding workflow, especially in the absence of standard best practices. Moreover, this may help health care providers in other institutions to develop policies regarding HCWs during similar pandemics.

As mentioned above, some studies showed that about 10% of all those infected with COVID-19 in some European countries are HCWs. 4 However, in this study, we found that the prevalence of positive-COVID-19 among asymptomatic HCWs who take care of patients infected with the novel coronavirus was 0%. Although this result could be in part due to our policies and protective measures, it was unexpected and against our assumption as HCWs are high risk group.

Potential explanations for this difference in the result are; firstly, the majority of admitted patients to our hospital were asymptomatic 88% and detected by epidemiological investigation teams as patients are most infectious when they are symptomatic. Secondly, rRT-PCR test has risk of eliciting false-negative results especially in asymptomatic cases due torelatively lowviral loads. Additionally, we used nasopharyngeal swab sampling. However, the optimum sample types during infections caused by COVID-19 remain to be fully determined and require expertise. 12 The findings of this study have to be seen in light of some limitations. The first is the limited number of COVID-19 patients admitted to our hospital. The second limitation concerns the timing of screening which was 4 weeks after the admission of the first COVID-19 patient, during this period, HCWs may have been infected with the virus at some point and recovered by the time of screening. Additionally, this is an empiric way of screening due to lack of previous research studies that address this subject.

It is worth mentioning that among the 385 HCWs assigned to deal with COVID-19 patients only two nurses were infected. First case was male aged 27 years who was diagnosed after he developed symptoms at the beginning of his fist shift, most probably that he had infected outside the hospital. He was excluded from the study because he was symptomatic and the inclusion criterion was only asymptomatic HCWs. The second case was 28-year-old asymptomatic female, she diagnosed by rRT-PCR due to history of contact with her infected colleague and she was excluded from the study as the source of infection was outside the hospital. This represents only 0.5 % of total HCWs. Importantly, this is a rapidly moving topic of research. Therefore, our result must be cautiously interpreted and should not give us a false sense of security regarding the prevalence of positive COVID-19 among HCWs. Our perspective is to improve surveillance of HCWs and to identify the best approach to protect HCWs in order to assure source control to insure a safe working environment.

Unexpectedly, the prevalence of positive COVID-19 among asymptomatic HCWs who take care of patients infected with the novel coronavirus was 0%. This result must be cautiously interpreted. Further studies are needed in order to find effective strategy of screening HCWs to insure a safe working environment.

Provenance and peer review Not commissioned, externally peer reviewed. • The prevalence of positive COVID-19 among asymptomatic HCWs was 0%.

• The result should not give us a false sense of security

• Improvement of surveillance and protection of HCWs is important

Face masks for the public during the covid-19 crisis

Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status

Characteristics of Health Care Personnel with COVID-19-United States

Are interventions such as social distancing effective at reducing the risk of asymptomatic healthcare workers transmitting COVID-19 infection to other household members

Guideline: Strengthening the reporting of cohort studies in surgery

SARS--CoV--2infection in 86 healthcare workers in two Dutch hospitals in March2020

Covid-19 and the Need for Health Care Reform

In the era of corona virus: health care professionals'knowledge, attitudes, and practice of hand hygienein Saudi primary care centers: a cross-sectional study

Critical Supply Shortages -The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic

COVID-19 and the Risk to Health Care Workers: A Case Report

Ensuring and Sustaining a Pandemic Workforce

Real-time RT-PCR in COVID-19 detection: issues affecting the results. EXPERT REVIEW OF MOLECULAR

The following information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories then this should be stated.

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.The authors declare that they have no competing interests.Please state any sources of funding for your research All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.

Research studies involving patients require ethical approval. Please state whether approval has been given, name the relevant ethics committee and the state the reference number for their judgement.

Studies on patients or volunteers require ethics committee approval and fully informed written consent which should be documented in the paper.Authors must obtain written and signed consent to publish a case report from the patient (or, where applicable, the patient's guardian or next of kin) prior to submission. We ask Authors to confirm as part of the submission process that such consent has been obtained, and the manuscript must include a statement to this effect in a consent section at the end of the manuscript, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request".Patients have a right to privacy. Patients' and volunteers' names, initials, or hospital numbers should not be used. Images of patients or volunteers should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. If such consent is made subject to any conditions, the Editor in Chief must be made aware of all such conditions. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.Written informed consent was waived due to the retrospective nature of the study

Please specify the contribution of each author to the paper, eg study concept or design, data collection, data analysis or interpretation, writing the paper, others, who have contributed in othe ways should be listed as contributors.All authors contributed significantly and in agreement with the content of the article. All authors were involved in project design, data collection, analysis, statistical analysis, data interpretation and writing the manuscript. All authors presented substantial contributions to the article and participated of correction and final approval of the version to be submitted.

In accordance with the Declaration of Helsinki 2013, all research involving human participants has to be registered in a publicly accessible database. Please enter the name of the registry and the unique identifying number (UIN) of your study.You can register any type of research at http://www.researchregistry.com to obtain your UIN if you have not already registered. This is mandatory for human studies only. Trials and certain observational research can also be registered elsewhere such as: ClinicalTrials.gov or ISRCTN or numerous other registries.

The Guarantor is the one or more people who accept full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish Nabil Al-zoubi